These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 23986165)
1. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials. Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165 [TBL] [Abstract][Full Text] [Related]
2. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis. Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826 [TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis. Parish LC; Parish JL; Routh HB; Fleischer AB; Avakian EV; Plaum S; Hardas B J Drugs Dermatol; 2011 Nov; 10(11):1282-8. PubMed ID: 22052309 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Naftifine HCl Cream 2% in the Treatment of Pediatric Subjects With Tinea Corporis. Gold M; Dhawan S; Verma A; Kuligowski M; Dobrowski D J Drugs Dermatol; 2016 Jun; 15(6):743-8. PubMed ID: 27272083 [TBL] [Abstract][Full Text] [Related]
5. A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris. Parish LC; Parish JL; Routh HB; Avakian E; Olayinka B; Pappert EJ; Plaum S; Fleischer AB; Hardas B J Drugs Dermatol; 2011 Oct; 10(10):1142-7. PubMed ID: 21968664 [TBL] [Abstract][Full Text] [Related]
6. An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea Pedis. Verma A; Olayinka B; Fleischer AB J Drugs Dermatol; 2015 Jul; 14(7):686-91. PubMed ID: 26151784 [TBL] [Abstract][Full Text] [Related]
7. The Role of Naftifine HCl 2% Gel and Cream in Treating Moccasin Tinea Pedis. Vlahovic TC J Drugs Dermatol; 2016 Feb; 15(2 Suppl):s56-9. PubMed ID: 26885800 [TBL] [Abstract][Full Text] [Related]
8. Naftifine gel in the treatment of tinea pedis: two double-blind, multicenter studies. Naftifine Gel Study Group. Cutis; 1991 Jul; 48(1):85-8. PubMed ID: 1868748 [TBL] [Abstract][Full Text] [Related]
9. Econazole nitrate foam 1% for the treatment of tinea pedis: results from two double-blind, vehicle-controlled, phase 3 clinical trials. Elewski BE; Vlahovic TC J Drugs Dermatol; 2014 Jul; 13(7):803-8. PubMed ID: 25007362 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Naftifine Hydrochloride 2% Gel in Interdigital Tinea Pedis: A Phase III Randomised, Double-Blind, Parallel-Group, Active-Controlled Study in Indian Adult Patients. Sinha SD; Rajamma A; Bandi MR; Sriramadasu SC; Sahu S; Kothiwala RK; Halder S; Sankerneni A; Panapakam M; Vemireddy VNR; Vattipalli R; Devireddy SR Clin Drug Investig; 2023 Jul; 43(7):565-574. PubMed ID: 37462803 [TBL] [Abstract][Full Text] [Related]
11. Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. Naftifine Podiatric Study Group. J Am Podiatr Med Assoc; 1990 Jun; 80(6):314-8. PubMed ID: 2189989 [TBL] [Abstract][Full Text] [Related]
12. An open-label study of naftifine hydrochloride 1% gel in the treatment of tinea versicolor. Gold MH; Bridges T; Avakian E; Plaum S; Pappert EJ; Fleischer AB; Hardas B Skinmed; 2011; 9(5):283-6. PubMed ID: 22165042 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study. Jarratt M; Jones T; Adelglass J; Bucko A; Pollak R; Roman-Miranda A; Olin JT; Swinyer L J Drugs Dermatol; 2014 Jul; 13(7):838-46. PubMed ID: 25007368 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial. Gupta AK; Skinner AR; Cooper EA Int J Dermatol; 2005 Jul; 44(7):590-3. PubMed ID: 15985032 [TBL] [Abstract][Full Text] [Related]
15. Ciclopirox gel in the treatment of patients with interdigital tinea pedis. Aly R; Fisher G; Katz I; Levine N; Lookingbill DP; Lowe N; Menter A; Morman M; Pariser DM; Roth HL; Savin RC; Shavin JS; Stewart D; Taylor JR; Tucker S; Wortzman M Int J Dermatol; 2003 Sep; 42 Suppl 1():29-35. PubMed ID: 14567368 [TBL] [Abstract][Full Text] [Related]
16. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis]. Klaschka F; Gartmann H; Weidinger G Z Hautkr; 1984 Sep; 59(18):1218-26. PubMed ID: 6388170 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study. Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050 [TBL] [Abstract][Full Text] [Related]
18. Detection and relevance of naftifine hydrochloride in the stratum corneum up to four weeks following the last application of naftifine cream and gel, 2%. Plaum S; Verma A; Fleischer AB; Olayinka B; Hardas B J Drugs Dermatol; 2013 Sep; 12(9):1004-8. PubMed ID: 24002147 [TBL] [Abstract][Full Text] [Related]
19. Luliconazole for the treatment of interdigital tinea pedis: A double-blind, vehicle-controlled study. Jarratt M; Jones T; Kempers S; Rich P; Morton K; Nakamura N; Tavakkol A Cutis; 2013 Apr; 91(4):203-10. PubMed ID: 23763082 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of interdigital tinea pedis]. Korting HC; Rychlik R; Pfeil B Dtsch Med Wochenschr; 2003 Sep; 128(36):1819-24. PubMed ID: 12964099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]